all the following statements about hybridoma technology are true except :
myeloma cells lack HGPase enzyme hence they cannot grow well in HAT medium APPLICATION OF HYBRIDOMA TECHNOLOGY Serological, * Identification of ABO blood group Diagnosis: * Detection of pregnancy by assaying of hormones with monoclonal. * Separation of one substance from a mixture of very similar molecules. Immunopurification: * Purification of individual interferon using monoclonal. * Inactivation of T-Iymphocytes responsible for rejection of organ transplants. Therapy: * Removal of tumor cell from bone marrow. * Treatment of acute renal failure. * Treatment malignant leukemic cells, B cell lymphomas, and a variety of allograft rejections after transplantation. ref : ananthanaryana 9th ed